Long-Term Outcome of Adenosine Deaminase-Deficient Patients-a Single-Center Experience.

about

First Occurrence of Plasmablastic Lymphoma in Adenosine Deaminase-Deficient Severe Combined Immunodeficiency Disease Patient and Review of the Literature.

P2860

Q49884908-0E224D56-17E4-4D7B-989D-8D843EFDA73C

P2860

Long-Term Outcome of Adenosine Deaminase-Deficient Patients-a Single-Center Experience.

Item

http://www.wikidata.org/entity/Q40117791

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Long-Term Outcome of Adenosine Deaminase-Deficient Patients-a Single-Center Experience.

@en

type

Item

label

Long-Term Outcome of Adenosine Deaminase-Deficient Patients-a Single-Center Experience.

@en

prefLabel

Long-Term Outcome of Adenosine Deaminase-Deficient Patients-a Single-Center Experience.

@en

P1476

Long-Term Outcome of Adenosine Deaminase-Deficient Patients-a Single-Center Experience

@en

P2093

Adelle R Atkinson

http://www.w3.org/2001/XMLSchema#string

Anne Pham-Huy

http://www.w3.org/2001/XMLSchema#string

Brenda Reid

http://www.w3.org/2001/XMLSchema#string

Eyal Grunebaum

http://www.w3.org/2001/XMLSchema#string

Ori Scott

http://www.w3.org/2001/XMLSchema#string

Vy Hong-Diep Kim

http://www.w3.org/2001/XMLSchema#string

P2860

Adenosine-dependent airway inflammation and hyperresponsiveness in partially adenosine deaminase-deficient mice

Metabolic consequences of adenosine deaminase deficiency in mice are associated with defects in alveogenesis, pulmonary inflammation, and airway obstruction

Immunodeficiency-associated lymphomas.

Myeloid dysplasia and bone marrow hypocellularity in adenosine deaminase-deficient severe combined immune deficiency.

Outcomes of patients with severe combined immunodeficiency treated with hematopoietic stem cell transplantation with and without preconditioning

B-cell development and functions and therapeutic options in adenosine deaminase-deficient patients.

Regulatory T cell-mediated anti-inflammatory effects promote successful tissue repair in both indirect and direct manners

Management options for adenosine deaminase deficiency; proceedings of the EBMT satellite workshop (Hamburg, March 2006).

Neuroprotective effects of adenosine deaminase in the striatum.

How I treat ADA deficiency.

P2888

s10875-017-0421-7

P304

582-591

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10875-017-0421-7

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Alessandro Aiuti

P577

2017-07-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1090902593

http://www.w3.org/2001/XMLSchema#string

P698

28748310

http://www.w3.org/2001/XMLSchema#string

Long-Term Outcome of Adenosine Deaminase-Deficient Patients-a Single-Center Experience.

about

P2860

P2860

Long-Term Outcome of Adenosine Deaminase-Deficient Patients-a Single-Center Experience.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698